Phibro Animal Health (PAHC) Other Non-Current Liabilities (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Other Non-Current Liabilities came in at $1.2 million in Q1 2026, down 89.85% year-on-year from $12.2 million in Q1 2025, and down 88.21% quarter-over-quarter from $10.5 million in Q4 2025.
Phibro Animal Health (PAHC) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
Phibro Animal Health's Other Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 89.85% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 89.85% decrease from a year earlier, with the FY2025 full-year figure at $79.3 million, up 1058.49% from the prior year.
- Other Non-Current Liabilities declined to $1.2 million in Q1 2026 per PAHC's latest filing, from $10.5 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $79.3 million in Q2 2025 and bottomed at $1.2 million in Q1 2026.
- The 5-year median for Other Non-Current Liabilities is $9.2 million (2022), against an average of $25.5 million.
- Across the five-year window, Other Non-Current Liabilities sank 89.96% in 2023 and surged 1119.56% in 2025, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $9.2 million in 2022, then dropped by 22.18% to $7.1 million in 2023, then surged by 65.0% to $11.8 million in 2024, then slipped by 11.05% to $10.5 million in 2025, then plunged by 88.21% to $1.2 million in 2026.
- Per Business Quant, the three latest PAHC Other Non-Current Liabilities figures stand at $1.2 million (Q1 2026), $10.5 million (Q4 2025), and $79.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.24 Mn |
| Dec 31, 2025 | 10.48 Mn |
| Sep 30, 2025 | 79.19 Mn |
| Jun 30, 2025 | 79.31 Mn |
| Mar 31, 2025 | 12.17 Mn |
| Dec 31, 2024 | 11.78 Mn |
| Sep 30, 2024 | 6.49 Mn |
| Jun 30, 2024 | 6.85 Mn |
| Mar 31, 2024 | 63.86 Mn |
| Dec 31, 2023 | 7.14 Mn |
| Sep 30, 2023 | 6.09 Mn |
| Jun 30, 2023 | 6.08 Mn |
| Mar 31, 2023 | 61.78 Mn |
| Dec 31, 2022 | 9.17 Mn |
| Sep 30, 2022 | 5.92 Mn |
| Jun 30, 2022 | 60.50 Mn |
| Mar 31, 2022 | 5.73 Mn |
| Dec 31, 2021 | 55.72 Mn |
| Sep 30, 2021 | 56.14 Mn |
| Jun 30, 2021 | 55.97 Mn |